 | Aligos Therapeutics, Inc. | |||
| NCM : ALGS || Location: United States | ||||
$0.79+0.01 (+0.78%) |
0.24 M | 0.76 - 0.82 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.869 M |
| March 15, 2024 | 0.366 M |
| Feb. 29, 2024 | 0.369 M |
| Feb. 15, 2024 | 0.317 M |
| Jan. 31, 2024 | 0.894 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.28 | -0.22 | 20.12% |
| 09/30/2023 | -0.48 | -0.41 | 15.38% |
| 06/30/2023 | -0.50 | -0.43 | 14.83% |
| 03/31/2023 | -0.49 | -0.53 | -7.14% |
| 12/31/2022 | -0.48 | -0.51 | -5.94% |
ALGS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 72.576M | Shares Float | 36.682M |
| Short Float | 0.869M | Market Cap | 57.34M |
| Institution ownership | 62.52% | Insider ownership | 21.073% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.36 | Forward EPS | -0.82 |